| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392826A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/03/2004 | EP1392825A1 Phosphotriesterase from agrobacterium radiobacter p230 |
| 03/03/2004 | EP1392824A2 Improved isoprenoid production |
| 03/03/2004 | EP1392823A2 Desaturase genes and uses thereof |
| 03/03/2004 | EP1392822A1 Double-transfected cell line useful for the identification of transport inhibitors |
| 03/03/2004 | EP1392821A1 Dna molecules encoding macaca mulatta androgen receptor |
| 03/03/2004 | EP1392820A1 Cyp450-specific dna probes and primers, and biological applications thereof |
| 03/03/2004 | EP1392818A1 Chimeric immunoreceptor useful in treating human cancers |
| 03/03/2004 | EP1392816A1 Production of bioavailable folic acid |
| 03/03/2004 | EP1392815A2 Enzymes having alpha amylase activity and methods of use thereof |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392731A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 03/03/2004 | EP1392730A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent |
| 03/03/2004 | EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 03/03/2004 | EP1392724A2 G-protein coupled receptor |
| 03/03/2004 | EP1392723A2 Medane genes and proteins |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1392715A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/03/2004 | EP1392712A2 Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 03/03/2004 | EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1392357A2 Vaccine composition |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392349A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 03/03/2004 | EP1392345A2 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis |
| 03/03/2004 | EP1392341A2 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof |
| 03/03/2004 | EP1392333A2 Manipulation of arterial-venous identity |
| 03/03/2004 | EP1392272A1 Permeation enhancers |
| 03/03/2004 | EP1392254A1 Micellar drug delivery systems for hydrophobic drugs |
| 03/03/2004 | EP1392112A2 Sca2 knockout animal and methods of use |
| 03/03/2004 | EP1392111A1 Method for targeting transcriptionally active loci |
| 03/03/2004 | EP1392106A1 Tyra genes and uses thereof |
| 03/03/2004 | EP1392105A2 Tobacco biomass utilization |
| 03/03/2004 | EP1392104A2 Sugar and lipid metabolism regulators in plants ii |
| 03/03/2004 | EP1160328B1 Frame adjust linkers |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1114161B1 Immunoglobulin binding protein |
| 03/03/2004 | EP1109571B1 Methods of treating salt-dependent hypertension |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP1025253B1 Positive-negative selection for homologous recombination |
| 03/03/2004 | EP1023467B1 Method for measuring viral infectivity |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | EP0973917B1 Agrobacterium mediated transformation of moulds, in particular those belonging to the genus aspergillus |
| 03/03/2004 | EP0964875B1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0906449B1 System and method for carrying out and monitoring polymerase chain reactions |
| 03/03/2004 | EP0904355B1 Method of activating denatured protein |
| 03/03/2004 | EP0871459B1 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 03/03/2004 | EP0831850B1 Use of locally applied dna fragments |
| 03/03/2004 | EP0797671B1 A process of producing extracellular proteins in bacteria |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0647268B1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
| 03/03/2004 | CN1479872A Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing allosteric regulatory site |
| 03/03/2004 | CN1479871A Diagnostic and theraputic methods based on L1 adhesion molecule for ovarian and endometrial tumors |
| 03/03/2004 | CN1479789A Genes of corynebacteria |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1479748A Anti-abnormal prion monoclonal antibody, process for producing the same and immunoassay method with the use thereof |
| 03/03/2004 | CN1479632A Complexes for transferring necleic acids into cells |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1479574A Treatment of corn seeds with clothianidin |
| 03/03/2004 | CN1479569A Modification of sucrose synthase gene expression in plant tissue and uses therefor |
| 03/03/2004 | CN1478903A Method of preparing human carried lipoprotein gene recombination protein |
| 03/03/2004 | CN1478898A Universal antibody target toward non-virus type lead-in system |
| 03/03/2004 | CN1478897A Plant polygene expression carrier, transforming factor containing said carrier and its application |
| 03/03/2004 | CN1478896A Method of colibacillus expression alpha foetoprotein |
| 03/03/2004 | CN1478895A Purified plyporus laccase and nucleic acid for coating the laccase |
| 03/03/2004 | CN1478894A Gene sequence of coded dominance inactive chalcone synzyme and its use |
| 03/03/2004 | CN1478893A Paddy rice anti-reverse transcripfactor and its coding gene and application |
| 03/03/2004 | CN1478890A Fermented soya bean thromboembolism enzyme and polynucleotide for coding said enzyme |
| 03/03/2004 | CN1478887A Yeast gene engineering fungus and beta mannosan enzyme preparation and production method of manna oligose |
| 03/03/2004 | CN1478791A Beta tubulin of cotton fiber and its coding gene and application |
| 03/03/2004 | CN1478790A Pronucleus preparation of nipple tumour virus capsid protein and application |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1478541A Design of high effect blood vessel production inhibitor and its application |
| 03/03/2004 | CN1140801C Method for detection of specific antigen reaction of lymphocyte in blood |
| 03/03/2004 | CN1140629C Genes of purine biosynthesis from ashbya gossypli and use thereof in microbial riboflavin synothesis |
| 03/03/2004 | CN1140628C Humaninterleukin-12 recombinant insect virus strain and its prepn. method |
| 03/03/2004 | CN1140627C Recombinant virus of human vascular endothelial growth inhibitor |
| 03/03/2004 | CN1140626C Recombination I-type herpes simplex virus and its application |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/02/2004 | US6701327 Merging network data sets comprising data acquired by interrogation of a network |
| 03/02/2004 | US6700040 Monopartite rna viral vector comprising modified tobravirus rna-1 consisting of an inserted forein rna sequence operably linked to the 3'-end of the stop codon of the rna sequence that codes for a 16 k da cysteine-rich protein in rna-1 |
| 03/02/2004 | US6700039 Use of target and organ specific promoters controlling expression of dna sequences inhibiting sprouting in plant vegetative storage organs (e.g., potato tubers) resulting in increased long term storage and minimal loss in food quality |
| 03/02/2004 | US6700038 Insect viral vectors useful in the transfer of genes to plants, insects and other hosts |
| 03/02/2004 | US6700037 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development |
| 03/02/2004 | US6699987 Isolation nucleic acids by binding to solid phase |
| 03/02/2004 | US6699986 Preferably at a ph of about 2 to about 4. |
| 03/02/2004 | US6699985 Administering a defibrotide |
| 03/02/2004 | US6699984 Genetic engineering in plants; dna sequences and constructs useful in controlling expression of recombinant genes in plants, constructs use novel regulatory sequences derived from maize root preferential cationic peroxidase gene |
| 03/02/2004 | US6699981 Generating prevential nucleotide sequences; obtain nucleotide sequences, incubate with primers, expose to polymerase, recover nucleotide sequences |
| 03/02/2004 | US6699979 Oligonucleotides having chiral phosphorus linkages |
| 03/02/2004 | US6699975 Fluorescent quenching detection reagents and methods |
| 03/02/2004 | US6699974 Reshaped human anti-HM 1.24 antibody |
| 03/02/2004 | US6699968 Fusion protein that includes a functional heparin sulfate attachment sequece placed into other proteins that normally do not have haparan sulfate glycosaminoglycan chains; links functional domains to biological effector molecules |